Artelo Biosciences annual ebitda
2018
2019
2020
2022
2023
2024
2025
Artelo Biosciences EBITDA Growth & History (ARTL)
Artelo Biosciences's calculated EBITDA was −$12.6M for fiscal 2025.
View full Artelo Biosciences company overviewArtelo Biosciences annual ebitda history
| Fiscal year | Period ended | EBITDA | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | −$12.6M | −$2.8M | — |
| 2024 | 2024-12-31 | −$9.8M | $104,000 | — |
| 2023 | 2023-12-31 | −$9.9M | $148,000 | — |
| 2022 | 2022-12-31 | −$10.1M | — | — |
| 2020 | 2020-08-31 | −$4.7M | −$1.5M | — |
| 2019 | 2019-08-31 | −$3.2M | −$865,812 | — |
| 2018 | 2018-08-31 | −$2.3M | — | — |
Artelo Biosciences quarterly ebitda
Q1.18
Q2.18
Q3.18
Q4.18
Q1.19
Q2.19
Q3.19
Q4.19
Q1.20
Q2.20
Q3.20
Q4.20
Q1.21
Q2.21
Q3.21
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | EBITDA | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | −$2.4M | $728,000 | — |
| Q1 2026 | 2026-03-31 | −$2.8M | −$462,000 | — |
| Q4 2025 | 2025-12-31 | −$4.1M | — | — |
| Q3 2025 | 2025-09-30 | −$3.0M | — | — |
| Q2 2025 | 2025-06-30 | −$3.1M | — | — |
| Q1 2025 | 2025-03-31 | −$2.4M | — | — |
| Q3 2021 · May 31 | 2021-05-31 | −$2.3M | −$1.3M | — |
| Q2 2021 · Feb 28 | 2021-02-28 | −$1.9M | −$497,037 | — |
| Q1 2021 | 2020-11-30 | −$1.4M | −$99,616 | — |
| Q4 2020 | 2020-08-31 | −$1.0M | −$74,201 | — |
| Q3 2020 | 2020-05-31 | −$951,271 | −$10,226 | — |
| Q2 2020 | 2020-02-29 | −$1.4M | −$612,561 | — |
| Q1 2020 | 2019-11-30 | −$1.3M | −$779,491 | — |
| Q4 2019 | 2019-08-31 | −$953,294 | −$263,244 | — |
| Q3 2019 | 2019-05-31 | −$941,045 | −$363,261 | — |
| Q2 2019 | 2019-02-28 | −$757,849 | $40,541 | — |
| Q1 2019 | 2018-11-30 | −$556,833 | −$279,848 | — |
| Q4 2018 | 2018-08-31 | −$690,050 | — | — |
| Q3 2018 | 2018-05-31 | −$577,784 | — | — |
| Q2 2018 | 2018-02-28 | −$798,390 | — | — |
| Q1 2018 | 2017-11-30 | −$276,985 | — | — |
Artelo Biosciences ebitda trends
Between the periods ended 2018-08-31 and 2025-12-31, Artelo Biosciences's ebitda decreased from −$2.3M to −$12.6M, a change of −$10.3M. The latest reported quarter, Q2 2026, shows −$2.4M.
About the metric
What EBITDA means
EBITDA is a measure of operating performance before interest, taxes, depreciation, and amortization. It can help compare operating results, but it is not a substitute for cash flow or GAAP net income.
Calculation and source
How TickerStat calculates EBITDA
TickerStat calculates EBITDA as operating income plus reported depreciation and amortization for aligned fiscal periods. It is calculated data, not adjusted EBITDA or company guidance. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Artelo Biosciences source filings ↗